News | September 22, 2021
Kotak Mahindra offers financing options for healthcare
The bank will provide a complete range of financing options including hospitals, labs, diagnostic centres and equipment manufacturers
The bank will provide a complete range of financing options including hospitals, labs, diagnostic centres and equipment manufacturers
With the MONALEESA-2 final analysis, only Kisqali has reported statistically significant overall survival (OS) benefit with an aromatase inhibitor for postmenopausal women with HR+/HER2- advanced breast cancer in the first-line (1L) setting
The approval will enable the treatment of patients in India living with Essential tremor, tremor-dominant Parkinson's Disease and neuropathic pain
The investment will be used to develop affordable Point of Care labs with 70+ tests. Mylab will start deploying systems with its lab partners from Nov 2021
The investment will be used to develop affordable Point of Care labs with 70+ tests. Mylab will start deploying systems with its lab partners from Nov 2021
The Lancet study said that Sputnik Light showed 78.6 to 83.7 per cent efficacy against Covid-19, significantly higher than most two-shot vaccines
Between 30-40 per cent of Covid-19 patients are either obese or diabetic
The pharma park will be built at an estimated cost of Rs 34.94 crore and will be spread over 50 acres at Chanho close to Ranchi
The first lot of IPV will be supplied to the government this month as per the requirement of the Health Ministry
_256_384.jpg)
Visby Medical’s instrument-free PCR test to detect the SARS-CoV-2 virus can now be used to pool up to five patient samples using a single test
Subscribe To Our Newsletter & Stay Updated
